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Abstract 
Background: Quality of the nucleic acids extracted from Formalin Fixed Paraffin Embedded (FFPE) samples largely 
depends on pre‑analytic, fixation and storage conditions. We assessed the differential sensitivity of viral and human 
double stranded DNA (dsDNA) to degradation with storage time.
Methods: We randomly selected forty‑four HPV16‑positive invasive cervical cancer (ICC) FFPE samples collected 
between 1930 and 1935 and between 2000 and 2004. We evaluated through qPCR the amplification within the same 
sample of two targets of the HPV16 L1 gene (69 bp, 134 bp) compared with two targets of the human tubulin-β gene 
(65 bp, 149 bp).
Results: Both viral and human, short and long targets were amplified from all samples stored for 15 years. In samples 
archived for 85 years, we observed a significant decrease in the ability to amplify longer targets and this difference 
was larger in human than in viral DNA: longer fragments were nine times (CI 95% 2.6–35.2) less likely to be recovered 
from human DNA compared with 1.6 times (CI 95% 1.1–2.2) for viral DNA.
Conclusions: We conclude that human and viral DNA show a differential decay kinetics in FFPE samples. The faster 
degradation of human DNA should be considered when assessing viral DNA prevalence in long stored samples, as 
HPV DNA detection remains a key biomarker of viral‑associated transformation.
Keywords: Human Papillomavirus 16, Invasive cervical carcinoma, Formalin‑Fixed Paraffin Embedded, Viruses, DNA, 
Degradation, Integrity, Sample storage, Stability
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Background
In pathology routine most biopsies and surgical samples 
are formalin fixed paraffin embedded (FFPE) to pre-
serve tissue structure and cellular morphology. Biobanks 
and FFPE sample collections constitute valuable sample 
sources because they allow to create and maintain well-
archived, extensive, easy to handle and relatively inex-
pensive sample repositories to perform large histological 
and molecular retrospective studies [1–3].
For molecular epidemiology studies, the information 
targeted is usually nucleic acid sequencing, but tissue 
preservation in paraffin blocks is variable and depends on 
a number of factors in the different steps of the process 
that affect quantity and quality of the extracted nucleic 
acids [4, 5]. One of the most important and studied fac-
tors is the type of the fixative chosen for the fixation 
step, with formalin being the commonest one. Formalin 
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fixation occurs through the formation of methylene 
bridges between the aldehyde group in the fixative and 
the amino groups in nucleic acids and proteins [6]. Over-
fixation or the use of a fixative molecule with multiple 
active groups, e.g. glutaraldehyde, hardens the tissue by 
cross-linking multiple molecules and can induce physi-
cal fragmentation of the nucleic acids during extraction 
[7, 8]. If unbuffered, the aldehyde group in formalin can 
undergo chemical disproportionation, so that two mol-
ecules of formaldehyde yield one molecule of methanol 
and one molecule of formic acid. The exposure of DNA 
to methanol and formic acid can lead to DNA depuri-
nation and strand breaks [6, 9]. Overall, DNA damage 
induced by fixation conditions can hinder downstream 
applications based on amplification techniques [10, 11].
Other important factor for the effects of the fixation 
process on nucleic acid quality is the duration of storage 
period and in this regard the literature is contradictory. 
While certain studies describe that the use of FFPE speci-
mens stored for several years (i.e. samples stored between 
10 to 20  years)   has only minor effects on subsequent 
DNA analysis [12, 13], other authors show that the length 
of PCR-amplified fragments and whole genome ampli-
fied-fragments decreases with storage time even when 
coupled with optimized DNA extraction procedures [14].
Persistent infection by oncogenic Human Papilloma-
viruses (HPVs) is the major risk factor for the develop-
ment of cervical cancer and is associated with most anal 
and vaginal cancers, as well as with a significant frac-
tion of vulvar, penile and oropharyngeal cancers [15]. 
Most assays for screening and diagnosis of HPVs-related 
diseases rely on the detection of viral nucleic acids and 
include amplification steps, often using consensus or 
multiplexed PCR [16]. Although fixation and storage 
affect the efficiency of consensus PCR assays for HPVs 
detection, FFPE specimens remain a crucial source for 
molecular epidemiology purposes when fresh clinical 
material is unavailable -which is often the case- making 
it possible to perform large retrospective studies corre-
lating molecular features with therapeutic response and 
clinical outcome [17–21].
This work was designed to evaluate the differential 
impact of time storage on the quality, quantity and deg-
radation of viral and human DNA employing a quan-
titative PCR on FFPE invasive cervical cancer samples 




Samples used in this study belonged to a repository 
including FFPE of primary invasive squamous cell cer-
vical cancer tissues from hospital pathology archives. 
Among all centers that had supplied samples for the his-
toric retrospective study, we focused on the one single 
institution that maximized time span [21]. By using a sin-
gle source, we intended to homogenize sample treatment 
and procedures. The procedures employed for FFPE 
sectioning, DNA purification and HPV DNA detection 
and genotyping have been previously described [21–23]. 
Samples had been formalin fixed under standard condi-
tions, using a 10% v/v of a formaldehyde (gas) saturated 
solution in water, corresponding to a final concentra-
tion of 3.7–4.0% w/v formaldehyde. As it became a com-
mon practice in anatomopathology departments over 
the world, from late 1990s this fixative solution was pre-
pared using phosphate buffer saline, to prevent formal-
dehyde disproportionation that can occur during long 
time storage if unbuffered. Briefly, four 5-µm paraffin 
sections were systematically obtained from each block. 
The first and last sections were used for histopathologi-
cal assessment, and the second and third sections were 
used for backup and analysis of HPVs DNA, respectively. 
DNA was released by incubation of the tissue sections for 
16 h at 56  °C with 250 µL buffer (10 mg/mL proteinase 
K, 50 mM Tris–HCl, 1.0 mM EDTA, 0.5% Tween 20, pH 
8.0), followed by 10  min at 95  °C to inactivate the pro-
tease. HPV DNA detection were performed through 
PCR-DEIA using a consensus primers  (SPF10) that target 
the L1 gene and amplify a 65 base pairs (bp) fragment. 
HPV DNA genotyping of positive samples was per-
formed employing LiPA25 system (version 1; DDL Diag-
nostic Laboratory, Rijswijk, The Netherlands) [24, 25]. 
Samples were stored at − 80 °C.
The selection of the samples for this study was 
restricted to invasive cervical cancer (ICC) cases hav-
ing tested positive exclusively for the presence of HPV16 
DNA, this way reducing the possible competition 
between different HPVs for the primers during amplifica-
tion step. We chose fifty HPV16-positive ICC samples, 25 
samples collected between 1930 and 1935, i.e. archived 
for 80–85 years and referred to as 85 years storage, and 
25 samples between 2000 and 2004, i.e. archived for 
11–15 years and referred to as 15 years storage. We dou-
ble-checked as far as possible the actual nature of the fix-
ative used in these samples treated in the 30s. Exhaustive 
searches confirmed that 19 of these samples had actually 
been fixed using formalin solution. However, three of the 
samples had been treated with the so-called Zenker solu-
tion as fixative, a mixture using heavy cations in an acid 
environment [22] while for three of the samples we could 
not elucidate with certainty the fixative. For this reason, 
and given that we could not find any additional sample 
fulfilling the criterion of single-infection by HPV16 from 
this period, we decided to perform the laboratory analy-
ses on all 50 samples, but to run the statistical analyses 
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only on using the 19 samples from the 30s for which we 
can assure they have been fixed in formalin. Neverthe-
less, we present the results for the full comparison. All 
results are similar both in trend as well as in significance 
level of the corresponding comparisons.
Quantitative PCR assay
Primers were designed through Primer3 plus (http://
www.bioin forma tics.nl/cgi-bin/prime r3plu s/prime r3plu 
s.cgi/) to amplify fragments no longer than 200 bp with 
similar amplicon sizes (differences of ± 15  bp), melting 
temperatures (around 64 °C), and GC content (50%). For 
the detection of HPV16 DNA, we targeted the L1 gene 
as the most conserved open reading frame at the nucle-
otide level within Papillomaviruses [26]. For the detec-
tion of human DNA we chose tubulin-β gene, which had 
been used for quality control purposes of the original 
FFPE repository [19]. For the tubulin-β gene we verified 
the conservation of the primer targets in the available 
Human 1000 Genomes (TUBB, hg38 chr6:30,720,352–
30,725,422), and the absence of off-target amplification 
by means of primer-BLAST (https ://www.ncbi.nlm.nih.
gov/tools /prime r-blast /). PCR systems were designed to 
respectively amplify two fragments of 69 bp and 134 bp 
within L1, and 65  bp and 149  bp in tubulin-β, employ-
ing for each gene a common forward primer and two dif-
ferent reverse primers. Primer sequences and amplicon 
sizes are shown in Table 1.
To maximize and improve the DNA yield from the 
stored samples, a recovery protocol was applied before 
amplification that included a pre-heat step of 60 °C dur-
ing 48 h to facilitate the release of DNA adsorbed to the 
plastic walls of the tubes. The concentration of DNA was 
measured with Qubit dsDNA HS Assay kit (Invitrogen, 
Life Technologies, CA, USA) on a Qubit 3.0 Fluorometer 
(Invitrogen, Life Technologies, CA, USA) according to 
manufacturer’s instructions.
SYBR-green based quantitative PCR (qPCR) was per-
formed in 20 µL reaction mix containing FastStart Essen-
tial DNA Green Master (Roche Molecular Systems, 
Branchburg, NJ, USA), 0.3  µM of each forward and 
reverse primer, and 2 µL of DNA. qPCR amplification 
was performed using the LightCycler® 96 Real-Time 
PCR System (Roche Molecular Systems) programmed for 
10 min at 95  °C, followed by 40 cycles of 10  s at 95  °C, 
10 s at 64 °C and 10 s at 72 °C. After data acquisition, the 
cycle threshold value was calculated by determining the 
point at which the fluorescence reached the threshold 
limit of 0.2. Following amplification, melting curve analy-
sis was performed to assess the nature of the PCR prod-
uct using a melting program with an increase of 2.2 °C/s 
from 65 °C to 97 °C. The standard curve used for quan-
tification of tubulin-β was performed with 7-fold serial 
1:5 dilutions of human genomic DNA (Roche Molecular 
Systems) starting with 0.2  mg/mL. For tubulin-β quan-
tification we considered that one cell contains approxi-
mately 6 pg of DNA and that a diploid cell contains two 
copies of tubulin-β. For L1 quantification, the standard 
curve was performed using 7-fold serial 1:5 dilutions of 
an international standard for HPV16 (NIBSC, London, 
UK). According to manufacturer’s instructions HPV16 
plasmid stock was 1.0 ×  107 genome equivalents/mL. All 
samples and controls were tested in technical triplicates, 
and were considered positive for the analysis when the 
quantification cycle (Cq) value for either tubulin-β or L1 
was below 35 cycles. Quantification of human and viral 
DNA was expressed as copies per µL.
Statistical analyses
Analyses were conducted with R statistical package (ver-
sion 3.2.5). We calculated Exact McNemar’s test to evalu-
ate the discordant results. We also used Fisher’s exact 
tests for the comparison of presence/absence of viral and 
human PCR amplification. For quantitative variables, 
comparisons were performed using the Wilcoxon rank-
sum in the case of unpaired values and the Wilcoxon 
signed-rank test in the case of paired values. All tests 
were two-tailed and the cut off value for significance was 
set at p < 0.05.
Results
Overall concentration of DNA retrieved from FFPE samples.
The DNA concentration in samples stored for 15  years 
was around 25% higher than in those stored for 85 years. 
Respective median values were 5.2 ng/µL (IQR: 3.2–11.0) 
and 1.2  ng/µL (IQR: 0.6–1.6) (Wilcoxon rank sum test, 
p = 2.6*10–6).
Differential quality of viral and human DNA retrieved 
from FFPE samples with storage time.
We analyzed first the differential amplification ability 
of long and short fragments in human and viral DNA 
between samples with the same storage time. In all 
Table 1 Primers sequences for human and viral PCR 
amplification
Primers Sequence 5′– 3’ Amplicon Size
TUBB‑F TCC TCC ACT GGT ACA CAG GC —
TUBB‑R1 CAT GTT GCT CTC AGC CTC GG 65 bp
TUBB‑R2 CTC CTC TTC GGC CTC CTC AC 149 bp
HPV16_L1‑F AAT AGG GCT GGT RCT GTT GG —
HPV16_L1‑R1 TGC AGT AGA CCC RGA GCC TT 69 bp
HPV16_L1‑R2 ATT TGG GCA TCA GAG GTA ACCAT 134 bp
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(100%) samples stored for 15  years, we could success-
fully amplify the two fragments sizes for both human and 
viral DNA. In the set of samples archived for 85  years, 
for both human and viral DNA, when the long ampli-
con was generated the corresponding short amplicon 
was also retrieved. In samples stored for 85 years, overall 
congruence between the amplification results obtained 
for human and for HPV16 DNA (Table 2) was low (21% 
concordance). This weak concordance reflected that 
human DNA amplification of the long fragment was less 
likely than that of the short fragment (respectively 2/19 vs 
17/19; Exact McNemar test, p = 6.1*10–5), while for viral 
DNA this difference was not observed (12/19 vs 16/19; 
Exact McNemar test, p = 0.125).
We analyzed  the differential amplification ability of 
the same DNA target in different samples with regards to 
the storage time. We did not observe differences between 
samples stored for 85 and for 15 years in the potential for 
generating the short amplification product, neither for 
human DNA (17/19 vs 25/25, Fisher’s Exact test; p = 0.18) 
nor for HPV16 DNA (16/19 vs 25/25, Fisher’s Exact test; 
p = 0.07). In contrast, viral and human DNA responded 
very differently to FFPE to long-term storage regard-
ing the amplification of longer products. Human DNA 
amplification potential dropped significantly: 25/25 after 
15  years and 2/19 after 85  years storage (Fisher’s Exact 
test; p = 2.5*10–10) (Table 2). The relative amplification of 
the long amplicon was thus nine times higher for samples 
with 15 years of storage than for samples with 85 years of 
storage (Risk ratio: 9.5; CI 95% 2.6–35.2). Regarding viral 
DNA instead, the decrease in amplification of the long 
product with time was far less important: 25/25 after 
15  years vs 12/19 after 85  years storage (Fisher’s Exact 
test; p = 1.3*10–3). In this case, the effect of storage time 
for the relative amplification was lesser (Risk ratio: 1.6; CI 
95% 1.1–2.2). Our results show therefore that FFPE long-
term storage decreased qualitatively the ability to recover 
longer DNA fragments by means of amplification, and 
that the impact of DNA degradation was more important 
for human than for HPV16 DNA.
Differential quantification of viral and human DNA 
retrieved from FFPE samples with storage time.
We have further quantitatively validated the results on 
the differential potential for amplification by means of 
qPCR. In all samples, quantification values for the short 
amplification target and for the long target were differ-
ent for both viral and human DNA (for 15 years storage, 
Wilcoxon signed rank test, p = 1.3*10–4 and p = 1.3*10–5, 
respectively for viral and human targets; for 85  years 
storage, Wilcoxon signed rank test, p = 4.8*10–4 and 
p = 3.2*10–4, respectively for viral and human targets). 
In both cases, the short fragment was estimated to be 
around four times more present than the long frag-
ment. Similarly, for samples archived for 85  years the 
values obtained using the short amplicon were different, 
approximately forty times more present, compared with 
the ones obtained when was amplified the long amplicon, 
both for human and HPV16. The results revealed a differ-
ential DNA quantification for human and HPV affected 
by the length of the amplicon, both in samples archived 
for 15 and for 85 years (Figs. 1 and Additional file 1: Fig. 
S1).
Discussion
Archived FFPE specimens are an invaluable source for 
molecular biological analyses, molecular epidemiology 
studies and/or identification of biomarkers. Tissue pres-
ervation in paraffin blocks is variable and dependent of 
multiple factors that influence nucleic acid integrity, 
potentially affecting the results for long-term retrospec-
tive analyses. Considering HPVs and the associated can-
cers, some studies have assessed the usefulness of FFPE 
samples and the different viral detection efficiency 
regarding distinct techniques [3, 24], while other have 
examined whether the storage period has significant 
effect on DNA, RNA or protein retrieval, however, focus-
ing solely in human macromolecules [2]. Additional 
research studied DNA amplification using different 
amplicon sizes [13], albeit without considering the differ-
ent origin of DNA, i.e. human or viral DNA. In the pre-
sent work we have tried to combine all these approaches 
to provide a complete picture on the quality and quantity 
of viral and human DNA retrieved from samples stored 
for 85 and 15 years, and using two sets of different sized 
amplicons (ca. 70  bp and ca. 150  bp) implemented in 
different qPCR systems on invasive cervical FFPE sam-
ples exclusively containing HPV16 as viral agent. Our 
Table 2 Score based on amplified fragments in the set of 
samples archived for 85 years
bp: base pairs
† All samples named “149 bp” were also positive for both 65 bp and 149 bp 
amplicons
‡  All samples named “134 bp” were also positive for both 69 bp and 134 bp 
amplicons
No. of samples amplified on human tubulin‑β 
gene
Negative Positive (65 bp) Positive 
(149 bp)†
Total
No. of samples amplified on HPV16 L1 gene
 Negative 0 3 0 3
 Positive (69 bp) 2 2 0 4
 Positive (134 bp)‡ 0 10 2 12
 Total 2 15 2 19
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results show that longer fragments of HPV dsDNA can 
be amplified from 80-years old FFPE samples compared 
with human dsDNA. Differential amplification could 
reflect increased chemical stability of the episomal, often 
supercoiled viral DNA and/or be related to the large 
number of copies per infected cell of viral DNA either in 
form of integrated concatemers or of episomes, as dis-
cussed below.
Our qualitative results for human and viral DNA detec-
tion describe higher efficiency and quality of amplifica-
tion with primers amplifying shorter fragments, in line 
with previous reports [25, 27]. Álvarez-Aldana and cow-
orkers amplified human and viral DNA from a set of 
FFPE cervical tissues stored for six years. They worked 
with 209 and 110 bp fragments in human β-globin gene 
and with 142 and 96 bp amplicons in HPV16 L1 and E6 
genes respectively, and they observed higher quality of 
detection in human DNA compared with HPV DNA 
[25]. The results from this study contrast with ours, but 
the origin for the lack of concordance lies probably at the 
primers used for viral amplification and at the ill-defined 
set of samples. Indeed, for the small HPV amplicon 
these authors used the GP5+/6+ set of generic primers 
[28], suited for a broad detection of HPVs but not spe-
cific enough for assessing sensitivity, and definitely not 
for a type-specific qPCR, which has been our choice for 
primer design. For the long HPV amplicon the authors 
used the TS16 primers, targeting HPV16 [25], but the 
actual genotype that could have been detected in the 
lesions had never been identified in forehand, so that a 
negative result is not necessarily informative. In our case, 
we have exclusively worked with samples containing 
HPV16, and our primers were designed with the same 
degree of specificity for the human and for the viral tar-
gets. In our hands, results from the PCR system on the 
human tubulin-β target are more dependent on the frag-
ment size than on the viral L1 gene. The same amplifica-
tion pattern for human DNA depending on amplicon size 
was observed by Nakayama and coworkers, who ampli-
fied different targets of the human gapdh gene from par-
affin samples (spanning from ≈300 bp to ≈1350 bp) and 
reported higher proportion of short amplicons, suggest-
ing less amplification efficiency for larger fragment sizes 
[29].
Regarding differential amplification with storage time, 
Ademà and coworkers studied FFPE DNA integrity of 
Human short Human long Viral short Viral long Human short Human long Viral short Viral long













Fig. 1 Violin plots comparing the distribution of the quantification values by gene, amplicon size and storage time including only the subset of 
samples fixed in formalin. For each period of time, median values of copies/µL (depicted as  Log10) per amplicon either between host and virus or 
for the two different amplicons within host and within viruses are compared by means of a Wilcoxon Mann–Whitney test. For each comparison, 
p‑values for the null‑hypothesis of non‑different median values between the corresponding distributions are indicated. Fragments are represented 
as follows: “Human short” to represent 65 bp tubulin‑β gene amplicon; “Human long” to represent 149 bp tubulin‑β gene amplicon; “Viral short” to 
represent 69 bp L1 gene amplicon and “Viral long” to represent 134 bp L1 gene amplicon. Each period of time is represented below fragments
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certain human genes between different storage periods 
and observed that DNA integrity decreased in FFPE sam-
ples stored with eight years of difference [1]. Our results 
spanning a longer period of time point in the same direc-
tion: with longer storage time, human DNA quality, as 
estimated by qPCR in terms of amplifiable length, is lower 
and only a minority of the analyzed samples remained 
equally amplifiable for short and long fragments. Fur-
thermore, we observed that the rates of amplification for 
short fragments either human or HPV are similar in spite 
of the time of storage (85 years of storage vs 15 years of 
storage), whereas for large fragments, we observed dif-
ferent amplification time trends, being more appreciable 
in human DNA than in viral. Specifically, whereas qual-
ity of human DNA was nine times more prone to amplify 
for samples storage 15  years than 85  years, viral DNA 
only was less than two times more prone. According to 
these time-differential PCR-fragments rates of amplifi-
cation observed, we suggest that PCR systems designed 
to amplify DNA fragments ≥ 150 bp from FFPE samples 
stored more than 70 years, may result in false negatives 
due to the decreased sensitivity of the PCR system.
Herráez-Hernández and coworkers compared differ-
ent HPV genotyping systems that include an initial PCR 
step of different fragments lengths [30]. They concluded 
that there are differences in sensitivity rates as function 
of amplicon size, suggesting that systems based on the 
amplification and genotyping of short HPV DNA frag-
ment size, for instance INNO-LiPA® HPV Genotyping 
(Fujirebio, Belgium) that includes the amplification of 
65  bp fragment through consensus primers  SPF10,  pre-
sent higher sensitivity to detect HPV DNA in FFPE sam-
ples than other techniques that work with larger DNA 
fragment, e.g. HPV2 CLART (Genomica, Spain) or Lin-
ear Array Genotyping test (Roche Molecular Systems), 
both detecting a 450 bp amplicon size. The same ampli-
fication pattern was described by Martró and coworkers 
comparing two HPV assays (INNO-LiPA® HPV Geno-
typing  and F-HPV typing™), which amplify fragments 
of respectively 158 bp and 484 bp in length in the E6/E7 
region, and reporting higher positivity for the approach 
using shorter amplicon size for initial steps [31]. In our 
work, we have additionally compared human and HPV 
PCR systems, in order to assess dependence of the sys-
tem performance. We observe that human and viral PCR 
systems perform differently for the same sample. We 
confirm that in FFPE samples, especially in those with a 
prolonged storage, amplification based-genotyping assays 
should use amplicons of around 60–70 bp in order to be 
highly sensitive. Furthermore, we propose that internal 
controls should not only be focused on human DNA, 
and if so, they should use amplicons of similar 60–70 bp 
length, as we have observed significant differences of 
PCR amplification with the tubulin-β gene, not detected 
for HPV DNA fragments.
Relating to the quantifying methodology implemented 
in our work, Nakayama and colleagues suggested that 
qPCR reflects more accurately the degree of DNA frag-
mentation than other techniques (e.g. UV or fluorescence 
spectroscopy) [28]. Thus, in our research we analyzed the 
trends intra and inter storage time-periods of the quan-
tification values, and we further explored the variance of 
these values when stratifying not only by time, but also 
by the DNA nature and the amplicon size. For all com-
parisons for the same storage time, amplicon size influ-
ences the quantification values, in all cases we obtained 
higher values of quantification for short fragments com-
pared with large. Dietrich and coworkers, developed a 
semi-nested qPCR system (a unique forward primer and 
different reverse primers) for the pitx2 human DNA gene 
covering 13 amplicon lengths ranging from 200 to 850 bp 
to be employed in FFPE samples collected between 1992 
and 2011. These authors did not observe viral load varia-
tion or qPCR inhibition, reporting Cq values of 40 when 
increasing the fragment length above 200/250  bp [10]. 
Dal Bello and colleagues quantified the viral load employ-
ing a qPCR system with the  SPF10 consensus primers on 
173 FFPE samples collected in three periods (1985–87; 
1995–97 and 2005–07), and they observed that HPV 
titers did not present differences attributable to dura-
tion in recently stored samples [32]. We propose that for 
studies in which the goal is to quantify human (target-
ing tubulin-β) or HPV DNA (targeting L1) in FFPE sam-
ples recently stored or stored ≥ 15  years through qPCR, 
the amplicon sizes should to be considered as one of the 
main variables to avoid possible under-estimation of the 
viral load or copies/µL. The obtained data could be help-
ful in deciding the design of qPCR amplification on FFPE 
samples with storage time below 15 years.
This study is subject to some a number of limitations. 
First, the paraffin employed for the embedding process 
has moved along the years to lower melting temperatures 
and consequently, the DNA purification could be differ-
entially impacted by an inefficient releasing in the initial 
steps in the samples archived for 85  years versus those 
archived for 15 years. In addition, the buffered formalin 
used beyond 2000 has shown higher PCR efficiency rates 
compared to unbuffered formalin. The more recent cases 
were collected from Portuguese Institutes of Oncology 
Francisco Gentil of Coimbra and Lisbon. In spite of the 
standardization of the routine sample processing in the 
institution, there could exist slight variations between 
both cities that could affect the preservation of the DNA 
in the tissues. A second limitation concerns the targeted 
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genes: only one gene per genome, viral and human. Our 
results of an increased lack of detection for human DNA 
with the time of storage suggest that it could be advis-
able to test multiple human gene to assess the suitability 
of a sample for epidemiological studies. Third, we have 
developed for this study a novel qPCR system. It was not 
our aim to exhaustively describing the sensitivity of this 
amplification system to detect HPV infections, and we 
have thus restrained ourselves to samples that had already 
been tested positive by using the very sensitive and well 
characterized  SPF10-DEIA-LiPA25 algorithm. Indeed 
two of the samples from the 1930s that had tested posi-
tive with the  SPF10 primers were negative with our novel 
primer set. Fourth, we have used in our study exclusively 
invasive cervical cancer samples, with the aim of stand-
ardizing the input material. Given that the HPV16 DNA 
in a cervical cancer lesion may be found integrated, as 
an episome or as a mixture of both, there may be certain 
degree of heterogeneity in the nature of the target DNA. 
Nevertheless, our study aims at providing a reference for 
epidemiological studies about causality as inferred from 
the association between disease and pathogen DNA 
recovery. Finally, our study was performed with a small 
sample size, obviously limited by the availability of appro-
priate samples from the 1930s. We would obviously have 
liked to work with a larger sample set to increase statis-
tical power. However, it was complicated to find addi-
tional FFPE samples fulfilling the criteria for inclusion in 
the study, largely because of the fixative considerations 
described above.
Conclusions
We conclude that for FFPE samples with a prolonged 
storage, time affects the performance of both viral and 
human PCR systems generally decreasing amplification 
viability for amplicons above ≥ 150  bp. This DNA deg-
radation with storage time is more evident for human 
DNA, which seems to present a faster decay kinetics than 
viral dsDNA. We hypothesize that the episomal nature 
of viral DNA may underlie this enhanced robustness of 
HPV16 DNA to chemical degradation. Overall, the dif-
ferential degradation behavior of human and viral DNA 
should be considered during the experimental design 
when assessing prevalence of viral DNA in ancient sam-
ples to prevent biases.
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